Vascular Grafts Market Size Expansion: Projected to Hit $3.99 Billion by 2029 with 4.3% Growth

 The Business Research Company’s report on the Vascular Grafts Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.

 
 What are the primary drivers fueling the growth of the vascular grafts market in recent years?
 The rising prevalence of vascular diseases is driving the growth of the global vascular grafts market. According to a study by the National Center for Biotechnology Information in the US, cardiovascular diseases are the leading cause of death in the world and according to the American Heart Association (AHA), the overall prevalence of myocardial infarction in the US was around 7.9 million per year, while the estimated annual incidence of a heart attack in the US is 720,000 new attacks and 335,000 recurrent attacks. According to a study by NHS Inform, a national health service of Scotland, every year around 20,000 coronary bypass grafts are carried out in England. Therefore, the high prevalence of vascular diseases is anticipated to drive the global vascular grafts market.
 
 Access Your Free Sample of the Global Vascular Grafts Market Report — Get Insights Now!
 https://www.thebusinessresearchcompany.com/sample.aspx?id=3419&type=smp
 
 What is the projected market size of the vascular grafts industry, and how is it expected to grow?
 The vascular grafts market size has grown steadily in recent years. It will grow from $3.25 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to increase in cardiovascular diseases (CVDs), increased geriatric population, strong economic growth in emerging markets, rise in healthcare expenditure and growth in the number of healthcare facilities.
 
 The vascular grafts market size is expected to see steady growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing number of renal diseases, increase in hypertension prevalence, sedentary lifestyles, rapid growth in the geriatric population, increase in diabetes, increase in cardiovascular diseases (CVDs) and rise in healthcare expenditure. Major trends in the forecast period include investing in the latest technology for improving the compliance with smaller vascular grafts, investing in technology such as 3D cell printing, for greater safety and ultimately higher success rates, investing in cell-free vascular grafts, investing in monitoring technology such as smart patches or self-monitoring devices and investing in research and development for newer and more innovative solutions to improve patient care.
 
 Gain Exclusive Market Insights — Customize Your Research Report Today For Fast Delivery!
 https://www.thebusinessresearchcompany.com/customise?id=3419&type=smp
 
 Who are the key players driving competition in the vascular grafts market?
 Major companies operating in the vascular grafts market include B. Braun Melsungen AG, Abbott Laboratories, Becton Dickinson and Company, Cardinal Health Inc., W. L. Gore & Associates Inc., Terumo Medical Corporation, Medtronic Plc, Getinge, Endologix, Cook Medical, MicroPort, CR Bard, Biovic, Creganna, Novomed Incorporation Private Limited, Marizyme Inc., Gore Medical, LeMaitre Vascular, Olympus Medical Systems Corporation, Japan Lifeline, JOTEC, Vascutek, RUA Life Sciences, Vascular Flow Technologies, Bolton Medical, Kips Bay Medical Incorporated, Cryolife, Vascular Graft Solutions Ltd.
 
 What key trends are expected to drive the vascular endothelial growth factor (vegf) inhibitor market during the forecast period?
 Companies in the vascular grafts market are increasingly investing in technological advances for the development of innovative vascular grafts, including customization of vascular grafts. For instance, RelayPro, a thoracic stent graft system recently launched by Terumo Aortic, is a low-profile device designed for patients with smaller access vessels in the treatment of thoracic endovascular aortic repair (TEVAR). It offers a broad range of diameters, lengths, tapers, and proximal configurations to the physicians. Both bare stent and non-bare stent (NBS) versions are available for this device, and they can be customized to meet the patient’s specific anatomical needs.
 
 Which key geographies are driving the growth of the vascular grafts market?
 North America was the largest region in the vascular grafts market in 2024. Western Europe was the second largest region in the vascular grafts market report. The regions covered in the vascular grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Order Your Report Now For Swift Delivery
 https://www.thebusinessresearchcompany.com/report/vascular-grafts-global-market-report
 
 What are the key segments driving growth in the vascular grafts market?
 The vascular grafts market covered in this report is segmented –
 
 1) By Product: Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft
 2) By Raw Material: Polyester Grafts, Polytetrafluoroethylene Grafts, Polyurethane Grafts, Biosynthetic Grafts
 3) By Application: Coronary Artery Disease, Aneurysm, Vascular Occlusion, Renal Failure
 4) By End-User: Hospitals, Ambulatory Surgical Centers
 
 Subsegments:
 1) Hemodialysis Access Graft: Synthetic Grafts, Biological Grafts
 2) Endovascular Stent Graft: Aneurysm Stent Grafts, Thoracic Stent Grafts, Abdominal Stent Grafts
 3) Peripheral Vascular Graft: Synthetic Grafts, Biological Grafts
 4) Coronary Artery Bypass Graft (Cabg): Arterial Grafts, Venous Grafts
 
 Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3419
 
 What defines the structure and scope of the vascular grafts market?
 The vascular grafts are used to repair the diseased or blocked blood vessel during the surgical procedure called vascular grafting or vascular bypass. Vascular grafting is performed to bypass a partial or complete blockage in an artery by reconnecting the blood vessels. This process improves the blood flow by redirecting blood from one area of the body to another.
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company